China (Mainland)
Premiumsupplier
Hemostatic Bp Standard Tranexamic Acid CAS 1197-18-8 CAS NO.1197-18-8
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,Other
- Product Details
Keywords
- Tranexamic Acid
- 1197-18-8
- trans-4-Aminomethylcyclohexane-1-carboxylate
Quick Details
- ProName: Hemostatic Bp Standard Tranexamic Acid...
- CasNo: 1197-18-8
- Molecular Formula: C8H15NO2
- Appearance: white Powder
- Application: Organic intermediate
- DeliveryTime: as customers request
- PackAge: 1-5KG/Tin or Bag,25KG/Drum, 200KG/Drum
- Port: any port in China
- ProductionCapacity: 1000 Metric Ton/Year
- Purity: >99%
- Storage: Cool Dry Place
- Transportation: by sea or by air
- LimitNum: 1 Kilogram
Superiority
| 1)Quick Response Within 12 hours; |
| 2)Quality Guarantee: All products are strictly tested by our QC, confirmed by QA and approved by third party lab in China, USA, Canada, Germany, UK, Italy, France etc. |
| 3) OEM/ODM Available; |
| 4) Reasonable & Competitive Price; |
| 5) Fast Delivery: Samples from stock; bulk products within 7 days; |
| 6) Professional Documents for Your Clearance; |
| 7) Economic Freight Save Your Cost; |
| 8) All your money be refund immediately if quality issue happens. |
Details
Product Details
|
Product Name
|
Tranexamic acid
|
|
Appearance
|
white powder
|
|
Assay by
|
HPLC
|
|
Mesh size
|
100% pass 80 mesh
|
|
Shelf life
|
2 years when properly stored
|
|
Package
|
drum and foil bag,or required by clients
|
|
Purity
|
99% Min, 99%
|
Tranexamic acid, also known as chloric acid, chemical name 4-aminomethyl cyclohexane formic acid, trade name Tosemin.Tranexamic acid (tranexamicacid) is a synthetic amino acid antifibrinolytic drug, which can competitively inhibit the binding of fibrin lysine to fibrinolytic enzyme, thus inhibit the cleavage of fibrin clot and produce hemostatic effect. it is mainly used in clinic for all kinds of bleeding caused by Chemicalbook caused by hyperfibrinolysis. Tranexamic acid is a synthetic lysine analogue, which can competitively bind the lysine binding site of plasminogen and plasmin, so as to competitively inhibit the degradation of fibrin, reduce the fibrinolytic activity and promote blood coagulation. In theory, the use of tranexamic acid can lead to insufficient fibrinolytic activity, so it is possible to increase the risk of postoperative thrombotic events.
Product Function
1.Tranexamic acid is mainly used for various types of bleeding caused by acute or chronic, localized or systemic fibrinolysis.
2. The melamine-removing effect of tranexamic acid is about 50 times higher than vitamin C and nearly 10 times that of fruit acid, so it can also be used for skin whitening.
3. Pay attention to the secondary high fibrinolysis state caused by disseminated intravascular coagulation, and use this product with caution before heparinization.